These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

535 related items for PubMed ID: 9918934

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
    Kanra G, Yalçin SS, Ceyhan M, Yurdakök K.
    Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
    [Abstract] [Full Text] [Related]

  • 50. Effect of hepatitis A vaccination programs for migrant children on the incidence of hepatitis A in The Netherlands.
    Suijkerbuijk AW, Lindeboom R, van Steenbergen JE, Sonder GJ, Doorduyn Y.
    Eur J Public Health; 2009 Jun; 19(3):240-4. PubMed ID: 19174503
    [Abstract] [Full Text] [Related]

  • 51. [Screening policy for travellers from Rotterdam for hepatitis A antibodies prior to eventual immunization: favourable cost-benefit ratio].
    Reintjes R, Bosman A, de Zwart O.
    Ned Tijdschr Geneeskd; 1999 Aug 28; 143(35):1777-80. PubMed ID: 10494329
    [Abstract] [Full Text] [Related]

  • 52. Cost-effectiveness of hepatitis A vaccination in children, adolescents, and adults.
    Rosenthal P.
    Hepatology; 2003 Jan 28; 37(1):44-51. PubMed ID: 12500187
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
    Wisløff T, Abrahamsen TG, Bergsaker MA, Løvoll Ø, Møller P, Pedersen MK, Kristiansen IS.
    Vaccine; 2006 Jul 17; 24(29-30):5690-9. PubMed ID: 16735083
    [Abstract] [Full Text] [Related]

  • 55. How do physicians immunize their own children? Differences among pediatricians and nonpediatricians.
    Posfay-Barbe KM, Heininger U, Aebi C, Desgrandchamps D, Vaudaux B, Siegrist CA.
    Pediatrics; 2005 Nov 17; 116(5):e623-33. PubMed ID: 16263976
    [Abstract] [Full Text] [Related]

  • 56. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA, Teufel A, Kanzler S, Shrestha A, Victor A, Otto G, Lohse AW, Galle PR, Höhler T.
    Am J Gastroenterol; 2008 Jan 17; 103(1):138-46. PubMed ID: 17970833
    [Abstract] [Full Text] [Related]

  • 57. [Immunity against hepatitis A in younger age groups and the basis for an immunization program].
    Puntarić D, Vodopija I, Baklaić Z, Ljubicić M.
    Lijec Vjesn; 1995 Jan 17; 117(7-8):167-72. PubMed ID: 8656973
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Effectiveness of universal hepatitis A immunization of children in Minsk City, Belarus: four-year follow-up.
    Fisenka EG, Germanovich FA, Glinskaya IN, Lyabis OI, Rasuli AM.
    J Viral Hepat; 2008 Oct 17; 15 Suppl 2():57-61. PubMed ID: 18837836
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.